BIO-key to Pitch Investors at DealFlow Conference Amid Authentication Market Growth
Event summary
- BIO-key International (BKYI) will present at the DealFlow Discovery Conference in Atlantic City, NJ, January 28-29, 2025.
- CEO Mike DePasquale will lead the presentation and be available for one-on-one investor meetings.
- The DealFlow Discovery Conference, formerly The Microcap Conference, caters to institutional investors, family offices, and high-net-worth individuals.
- BIO-key’s PortalGuard IAM solution secures access for over 40 million users.
The big picture
BIO-key operates in the rapidly expanding Identity and Access Management (IAM) market, driven by increasing cybersecurity threats and a shift towards passwordless authentication. The DealFlow Discovery Conference represents a strategic effort to attract institutional investment and broaden its investor base. The company’s success hinges on its ability to demonstrate a clear path to profitability and sustainable growth within a crowded and competitive market.
What we're watching
- Investor Reception
- The conference presentation and subsequent meetings will reveal the level of investor interest in BIO-key’s growth strategy and valuation, particularly given the competitive landscape in the authentication space.
- Market Adoption
- The pace at which BIO-key can expand its user base beyond the current 40 million will be critical for sustaining revenue growth and justifying its market capitalization.
- Competitive Pressure
- How BIO-key differentiates its offerings from larger, better-capitalized competitors in the passwordless authentication market will determine its ability to maintain market share and pricing power.
Related topics